血浆表面活性蛋白D与儿童急性呼吸衰竭的严重PARDS、延长通气及死亡相关
本研究为前瞻性队列研究,纳入350例急性呼吸衰竭患儿(233例为儿童ARDS),检测插管当日或后2天内首次血浆SP-D水平。校正年龄、PRISM-III及原发诊断后,SP-D升高与严重PARDS、死亡、机械通气时长、PICU住院时长及最高氧合指数相关。
要点
- SP-D升高亦与死亡、机械通气时长、PICU住院时长及最高氧合指数相关。
- SP-D水平随原发诊断不同而异(P<.001),并与年龄相关(rs=0.16,P=.002)。
核心结论
- 血浆SP-D升高与儿童急性呼吸衰竭的严重PARDS及不良结局相关。
- 未来需研究SP-D能否预测肺损伤程度、治疗反应或识别PARDS内型。
研究设计与样本
- 前瞻性队列研究,纳入2周至17岁急性呼吸衰竭患儿,参与BALI多中心研究。
- 分析350例患儿插管当日或后2天内首次血浆样本的SP-D水平,采用酶联免疫吸附法测定。
- 233例患儿符合儿童ARDS(PARDS)诊断。
主要发现
- SP-D水平在不同原发诊断间存在差异(P<.001)。
- SP-D升高与机械通气时长(P=.012)、PICU住院时长(P=.019)及最高氧合指数(P=.040)相关。
- SP-D水平与年龄相关(rs=0.16,P=.002)。
临床怎么用
- 在急性呼吸衰竭患儿中,早期血浆SP-D升高提示严重PARDS及不良结局风险,可辅助风险分层。
- SP-D目前尚不能用于预测肺损伤程度或治疗反应,需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elevated surfactant protein D (SP-D) is a relatively specific indicator of lung injury and is associated with both acute and chronic lung disease in adults and respiratory distress syndrome in premature infants. The relationship between plasma SP-D and lung injury in children with acute respiratory failure is unclear. RESEARCH QUESTION: Is plasma SP-D associated with lung injury or outcome in children with acute respiratory failure? STUDY DESIGN AND METHODS: This was a prospective cohort study in children 2 weeks to 17 years of age with acute respiratory failure who participated in the BALI multi-center study. Analyses were done using SP-D levels in plasma from the first sample taken on either the day of intubation or one of the following 2 days. SP-D level was measured by enzyme-linked immunosorbent assay. RESULTS: Plasma samples from 350 patients were used in the analysis; 233 had pediatric ARDS (PARDS). SP-D levels varied across primary diagnoses (P < .001). Elevated SP-D levels were associated with severe PARDS after adjusting for age, pediatric risk of mortality III (PRISM-III), and primary diagnosis (OR = 1.02; CI = 1.01-1.04; P = .011). Multivariable analyses also indicated that elevated SP-D levels were associated with death (OR = 1.02; CI = 1.01-1.04; P = .004), duration of mechanical ventilation (P = .012), PICU length of stay (P = .019), and highest oxygenation index (P = .040). SP-D levels also correlated with age (rs = 0.16, P = .002). INTERPRETATION: Elevated plasma SP-D levels are associated with severe PARDS and poor outcomes in children with acute respiratory failure. Future studies will determine whether SP-D can be used to predict the degree of lung injury or response to treatment and whether SP-D is useful in identifying PARDS endotypes.
引用
- Dahmer MK, Flori H, Sapru A, et al. Surfactant Protein D Is Associated With Severe Pediatric ARDS, Prolonged Ventilation, and Death in Children With Acute Respiratory Failure. Chest. 2020. PMID: 32275979. doi:10.1016/j.chest.2020.03.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。